(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-piperazin-1-yl-methanone, 95.0%, 5g

2-Amino-5-bromo-3-nitro-benzoic acid methyl ester, 97.0%, 1g

5-Methylpyridin-2(1H)-one, 98.0%, 100g

3-(Hydrazinylmethyl)pyridine hydrochloride, 95.0%, 250mg

Diclorometano, mínimo 99,5 %, para síntesis, 100 ml, envase de vidrio

N,N'-Di-2-naphthyl-1,4-phenylenediamine>95.0%(HPLC)500g

3-ethyl-1,2,4-oxadiazol-5-ol, 95.0%, 5g

4-(Pyrimidin-2-yloxy)benzonitrile, 95.0%, 5g

N-Methyl-aza-2,2,4-trimethylsilacyclopentane, 25g

[Hydroxy(tosyloxy)iodo]benzene>97.0%(T)5g

{2-[(3-methyl-1H-1,2,4-triazol-5-yl)thio]ethyl}amine dihydrochloride hydrate, 95.0%, 1g

3-Fluoro-5-methylpicolinic acid, 95.0%, 250mg

5-Bromo-4-chloro-3-indolyl beta-D-Glucuronide Sodium Salt [for Biochemical Research]>98.0%(HPLC)(T)100mg